Fecal Calprotectin Concentration in Neonatal Necrotizing Enterocolitis

Overview

Journal Korean J Pediatr

Specialty Pediatrics

Date 2014 Sep 12

PMID 25210522

Citations 19

Authors

Jung Min Yoon

Ju Yi Park

Kyung Ok Ko

Jae Woo Lim

Eun Jeong Cheon

Hyo Jeong Kim

Affiliations

Soon will be listed here.

Abstract

Purpose: Among the many factors associated with acute intestinal mucosal infection, numerous studies have proposed the usefulness of fecal calprotectin. The aim of this study was to evaluate the usefulness of fecal calprotectin in the diagnosis of necrotizing enterocolitis (NEC).

Methods: We collected 154 stool samples from 16 very low birth weight and premature newborns at the Konyang University Hospital neonatal intensive care unit or neonatal nursery. The stool samples were collected using the Calprest device, and the fecal calprotectin level was measured with the BÜHLMANN Calprotectin enzyme-linked immunosorbent assay kit.

Results: Fecal calprotectin levels were significantly higher in the NEC group than in the non-NEC group (P=0.02). There was a significant positive linear relationship between the fecal calprotectin level and number of days after birth (P=0.00) in the gestational age <26 weeks group. There was a significant negative linear relationship between the calprotectin level and number of days after birth (P=0.03) in the gestational age ≥26 weeks and <30 weeks group. There was no difference in the calprotectin levels according to the type and method of feeding between the NEC and non-NEC groups.

Conclusion: Fecal calprotectin levels were significantly increased in premature infants with NEC. The fecal calprotectin test is a noninvasive, easy, and useful tool for the diagnosis of NEC.

Citing Articles

Powdered human milk-derived versus bovine milk-derived breastmilk fortification: A multi-centre preterm randomised controlled trial.

Berrington J, Johnson M, Garg S, Stewart C, Lamb C, Palmer J J Pediatr Gastroenterol Nutr. 2024; 80(2):336-344.

PMID: 39660504 PMC: 11788938. DOI: 10.1002/jpn3.12431.

The effect of haemoglobin and blood transfusion on preterm infant gut perfusion and injury.

Howarth C, Mifsud C, Banerjee J, Eaton S, Leung T, Fleming P Front Pediatr. 2024; 12:1440537.

PMID: 39649403 PMC: 11620877. DOI: 10.3389/fped.2024.1440537.

Characteristics of fecal calprotectin as an early marker for suspected necrotizing enterocolitis in newborns exclusively fed maternal breast milk: a case-control study.

Farghaly M, Ali M, Ramey S, Said W, Abdelkarem A, Collin M Proc (Bayl Univ Med Cent). 2024; 37(1):43-47.

PMID: 38174026 PMC: 10761025. DOI: 10.1080/08998280.2023.2277580.

Fecal calprotectin as a non-invasive marker for the prediction of post-necrotizing enterocolitis stricture.

Chen G, Lv X, Tang W Pediatr Surg Int. 2023; 39(1):250.

PMID: 37594554 DOI: 10.1007/s00383-023-05534-7.

Postnatal Dynamics and Clinical Associations of Fecal Calprotectin in Very Preterm Infants: Implications for Necrotizing Enterocolitis and Feeding Intolerance.

Hong L, Huang Y, Jiang S, Han J, Li S, Zhang L Clin Transl Gastroenterol. 2023; 14(8):e00604.

PMID: 37272666 PMC: 10461937. DOI: 10.14309/ctg.0000000000000604.

References

Aydemir O, Aydemir C, Sarikabadayi Y, Canpolat F, Erdeve O, Biyikli Z . Fecal calprotectin levels are increased in infants with necrotizing enterocolitis. J Matern Fetal Neonatal Med. 2012; 25(11):2237-41. DOI: 10.3109/14767058.2012.684172. View

Klip H, Burger C, de Kraker J, van Leeuwen F . Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. Hum Reprod. 2001; 16(11):2451-8. DOI: 10.1093/humrep/16.11.2451. View

Roseth A, Aadland E, Jahnsen J, Raknerud N . Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion. 1997; 58(2):176-80. DOI: 10.1159/000201441. View

Reisinger K, van der Zee D, Brouwers H, Kramer B, van Heurn L, Buurman W . Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. J Pediatr Surg. 2012; 47(9):1640-5. DOI: 10.1016/j.jpedsurg.2012.02.027. View

Roseth A, Fagerhol M, Aadland E, Schjonsby H . Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol. 1992; 27(9):793-8. DOI: 10.3109/00365529209011186. View

Carroll D, Corfield A, Spicer R, Cairns P . Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. Lancet. 2003; 361(9354):310-1. DOI: 10.1016/S0140-6736(03)12333-1. View

Shulman R, Ou C, OBrian Smith E . Evaluation of potential factors predicting attainment of full gavage feedings in preterm infants. Neonatology. 2010; 99(1):38-44. PMC: 3214900. DOI: 10.1159/000302020. View

Roseth A, Schmidt P, Fagerhol M . Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol. 1999; 34(1):50-4. DOI: 10.1080/00365529950172835. View

Berstad A, Arslan G, Folvik G . Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid. Scand J Gastroenterol. 2000; 35(1):64-9. DOI: 10.1080/003655200750024551. View

10.

Thuijls G, Derikx J, van Wijck K, Zimmermann L, Degraeuwe P, Mulder T . Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg. 2010; 251(6):1174-80. DOI: 10.1097/SLA.0b013e3181d778c4. View

11.

Rouge C, Butel M, Piloquet H, Ferraris L, Legrand A, Vodovar M . Fecal calprotectin excretion in preterm infants during the neonatal period. PLoS One. 2010; 5(6):e11083. PMC: 2884033. DOI: 10.1371/journal.pone.0011083. View

12.

Golden B, Clohessy P, Russell G, Fagerhol M . Calprotectin as a marker of inflammation in cystic fibrosis. Arch Dis Child. 1996; 74(2):136-9. PMC: 1511506. DOI: 10.1136/adc.74.2.136. View

13.

Kristinsson J, Roseth A, Fagerhol M, Aadland E, Schjonsby H, Bormer O . Fecal calprotectin concentration in patients with colorectal carcinoma. Dis Colon Rectum. 1998; 41(3):316-21. DOI: 10.1007/BF02237485. View

14.

Josefsson S, Bunn S, Domellof M . Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr. 2007; 44(4):407-13. DOI: 10.1097/MPG.0b013e3180320643. View

15.

Isaacs D, North J, Lindsell D, Wilkinson A . Serum acute phase reactants in necrotizing enterocolitis. Acta Paediatr Scand. 1987; 76(6):923-7. DOI: 10.1111/j.1651-2227.1987.tb17265.x. View

16.

Burri E, Beglinger C . Faecal calprotectin -- a useful tool in the management of inflammatory bowel disease. Swiss Med Wkly. 2012; 142:w13557. DOI: 10.4414/smw.2012.13557. View

17.

Ton H, Brandsnes , Dale S, Holtlund J, Skuibina E, Schjonsby H . Improved assay for fecal calprotectin. Clin Chim Acta. 2000; 292(1-2):41-54. DOI: 10.1016/s0009-8981(99)00206-5. View

18.

Pourcyrous M, Korones S, Yang W, Boulden T, Bada H . C-reactive protein in the diagnosis, management, and prognosis of neonatal necrotizing enterocolitis. Pediatrics. 2005; 116(5):1064-9. DOI: 10.1542/peds.2004-1806. View

19.

Johne B, Fagerhol M, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen C . Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol. 1997; 50(3):113-23. PMC: 379605. DOI: 10.1136/mp.50.3.113. View

20.

Meling T, Aabakken L, Roseth A, OSNES M . Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs. Scand J Gastroenterol. 1996; 31(4):339-44. DOI: 10.3109/00365529609006407. View